Brind.

Coiled Therapeutics and Roquefort Therapeutics plc are identified as clinical-stage biotech companies.

2 reports, 1 independent Updated Sep 4
Gone quiet
Reports
2
Developments
2
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Coiled Therapeutics and Roquefort Therapeutics plc are identified as clinical-stage biotech companies.

How it developed

Newest first. Tap a step to see who reported it.
  1. Stephen West was appointed Non-Executive Director of Coiled Therapeutics, an AIM-listed UK biotech company.Sub-event
  2. Both Coiled Therapeutics and Roquefort Therapeutics plc are clinical-stage biotech companies.1 source

Coverage

Newest first; wire copies grouped
  • themarketsdaily.comRoquefort Therapeutics (LON:COIL) Trading Down 5% – What’s Next?
1 more outlet ran the same wire story